EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinie

Guidelines for Diagnosis and Treatment of Mucocutaneous Candidiasis

Takuro Katoh

Nippon Ishinkin Gakkai Zasshi · 2009 · 50 (4) · 207-212

DOI: 10.3314/jjmm.50.207 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nippon Ishinkin Gakkai Zasshi, 2009. Verfasst von Takuro Katoh. Beteiligte Einrichtung: Division of Dermatology, Saiseikai Kawaguchi General Hospital. Hauptthemen laut MEDLINE: Practice Guidelines as Topic. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 7 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This document summarizes current knowledge about diagnosis and treatment of candidiasis affecting the skin and oral mucosa. Several clinical forms of mucocutaneous candidiasis are distinguished depending on a patient's age and infected site, e.g. Candida intertrigo, erythema mycoticum infantile, erosio interdigitalis blastomycetica, candidal paronychia and onychia, Candida onychomycosis, and oral candidiasis. The diagnosis of candidiasis is confirmed by observation of mycelial forms on microscopic examination. Since Candida yeasts (especially C. albicans) are normal inhabitants of the skin and oral mucosa, it must always be noted that positive culture does not always indicate the presence of candidal infection. The pathogenicity of Candida species is relatively low, and some special conditions are required for tissue invasion by the fungus. Predisposing factors, such as disturbances of the cutaneous and mucosal microenvironment and systemic or local immunosuppression, should be checked in patients with recurrent infection. Therapy for cutaneous candidiasis is dominated by topical antifungal agents. Azole antifungal cream (e.g., bifonazole, ketoconazole, neticonazole hydrochloride, lanoconazole and luliconazole) is most effective. Terbinafine hydrochloride and amorolfine hydrochloride are also useful. Cutaneous candidiasis usually requires a shorter duration of topical treatment (1-2 weeks) than superficial dermatophyte infections. For candidal paronychia and onychomycosis, oral therapy with itraconazole is recommended. The daily dose of itraconazole should be taken for several months, while its pulse therapy for candidiasis is not approved in Japan. Itraconazole oral solution is commonly used for oral candidiasis, and miconazole gel is also effective.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Practice Guidelines as TopicAdministration, OralAdministration, TopicalAntifungal AgentsCandida albicansCandidiasis, Chronic MucocutaneousDrug Administration ScheduleHumansImidazolesKetoconazoleMicroscopyMorpholinesNaphthalenesTerbinafine

Substanzen

Antifungal AgentsImidazolesMorpholinesNaphthalenesamorolfineTerbinafinebifonazoleKetoconazole

Autor:innen und Institutionen

  • Division of Dermatology, Saiseikai Kawaguchi General Hospital.

Zitieren

APA

Katoh, T. (2009). Guidelines for Diagnosis and Treatment of Mucocutaneous Candidiasis. Nippon Ishinkin Gakkai Zasshi, 50(4), 207-212. https://doi.org/10.3314/jjmm.50.207

Vancouver

Katoh T. Guidelines for Diagnosis and Treatment of Mucocutaneous Candidiasis. Nippon Ishinkin Gakkai Zasshi. 2009;50(4):207-212. doi:10.3314/jjmm.50.207

BibTeX
@article{Katoh2009,
  author = {Katoh, Takuro},
  title = {Guidelines for Diagnosis and Treatment of Mucocutaneous Candidiasis},
  journal = {Nippon Ishinkin Gakkai Zasshi},
  year = {2009},
  volume = {50},
  number = {4},
  pages = {207--212},
  doi = {10.3314/jjmm.50.207}
}
Kostenlos starten →